Skip to main content
Stuart Rich, MD, Cardiology, Chicago, IL, Northwestern Memorial Hospital

StuartRichMD

Cardiology • Chicago, IL

Adult Congenital Heart Disease, Heart Failure & Transplantation, Vascular Medicine

Director, Pulmonary Vascular Disease Program, Bluhm Cardiovascular Institute; Professor of Medicine, Northwestern University Feinberg School of Medicine

Join to view full profile

Dr. Rich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rich's full profile

Already have an account?

Summary

  • Stuart Rich, M.D., is Director of the Bluhm Cardiovascular Institute Pulmonary Vascular Disease Program, and Professor of Medicine at the Northwestern University Feinberg School of Medicine. Dr. Rich did is residency in medicine at Washington University in St. Louis, and fellowship in cardiology at the University of Chicago. Dr. Rich is one of the world’s most recognized experts on pulmonary vascular diseases. For more than 3 decades he has dedicated his research and clinical efforts to finding better solutions for pulmonary hypertension. His career began at the University of Illinois where he was PI for the NIH Registry on Primary Pulmonary Hypertension, and has been the leader of the largest clinical center in the U.S. for evaluating and treating patients with pulmonary hypertension since 1980. Dr. Rich has conducted pioneering research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease. He has been a leader in the development of virtually every new treatment for pulmonary hypertension, as well as the use of therapeutic procedures and devices. His pioneering research has led to a greater understanding of all types of pulmonary hypertension.

    Dr. Rich has been listed among the country’s top 1% of doctors by Castle Connolly Ltd. and Chicago magazine for more than 20 consecutive years. He has published hundreds of clinical articles and book chapters on pulmonary hypertension. In addition, he is Co-Founder of the Pulmonary Vascular Research Institute, a global health professional organization that is committed to bringing advances in treating pulmonary vascular diseases to the developing world. In 2014 he received the Heart for Hope Legacy Award from the Pulmonary Hypertension Association, in 2015 he received the Lifetime Achievement Award from the Pulmonary Vascular Research Institute, and in 2016 was designated as a "Living Legend" by the ACC.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Cardiovascular Disease, 1978 - 1980
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1975 - 1978
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1974
  • University of Illinois, College of Liberal Arts and Sciences
    University of Illinois, College of Liberal Arts and SciencesB.S., General Biology, High Honors, 1967 - 1970
  • University of Illinois, College of Liberal Arts and Sciences
    University of Illinois, College of Liberal Arts and SciencesB.S., Biology, High Honors, 1967 - 1970
  • University of Chicago
    University of ChicagoM.A., Biologic Sciences

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1978 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Lifetime Achievement Award Pulmonary Vascular Research Institute, 2015
  • Americas Top Doctors Castle Connolly, 2015
  • Heart for Hope Legacy Award Pulmonary Hypertension Association, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension  
    Hemnes AR, Trammell AW, Archer SL, RICH S, Yu C, Nian H, Penner N, Funke M, Wheeler L, Robbins IM, Austin ED, Newman JH, West J, Circulation, 1/1/2015
  • Pharmacological therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report  
    Taichman D, Chung L, Klinger J, Lewis S, Mandel J, Ornelas J, Palevsky H, RICH S, Sood N, Trow T, Yung R, Elliott G, Badesch D, Chest, 1/1/2014
  • Clinical diagnosis of pulmonary hypertension  
    Rich JD, RICH S, Circulation, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Cardiology Clinics: The Faces of Right Ventricular Failure 
    Chapter: Right Ventricular Adaptation and Maladaptation in Chronic Pulmonary Arterial Hypertension. 
    Page 257 - 269RICH SEditors: Goldstein JA, Rich JD.Elsevier Saunders, Philadelphia, PA2012
  • Muscle: Fundamental Biology and Mechanisms of Disease 
    Chapter: The Right Ventricle: Reemergence of the Forgotten Ventricle 
    Page 537 - 553Archer SL, Ryan J, RICH S, Nathan S, Tsai K, Patel A, Fang Y, Piao LEditors: Hill JA, Olson EN.Springer Science, New York, NY2012
  • Muscle: Fundamental Biology and Mechanisms of Disease 
    Chapter: The Right Ventricle: Reemergence of the Forgotten Ventricle. Chapter 38 
    Page 537 - 553Archer SL, Ryan J, Rich S, Nathan S, Tsai K, Patel A, Fang Y, Piao LEditors: Hill JA. Olson EN.Springer Science, New York, NY2012
  • Join now to see all

Other

  • Primary Pulmonary Hypertension: Executive Summary from the World Symposium - Primary Pulmonary Hypertension 1998. 
    RICH S (Eds), World Health Organization
    http://web.archive.org/web/20020408173726/http://www.who.int/ncd/cvd/pph.html
    1/1/1998
  • Primary Pulmonary Hypertension: Executive Summary from the World Symposium – Primary Pulmonary Hypertension 1998. 
    Rich S, editor, World Health Organization
    http://web.archive.org/web/20020408173726/http://www.who.int/ncd/cvd/pph.html
    1/1/1998
  • Pulmonary hypertension and pulmonary embolism. 
    Moser K, Resnekov L, RICH S, Cardiology Video Journal
    1/1/1993
  • Join now to see all

Press Mentions

  • Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
    Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)August 5th, 2021
  • Northwestern Medicine Cardiologist First in Illinois to Use Novel Treatment for Chronic Pulmonary Embolism
    Northwestern Medicine Cardiologist First in Illinois to Use Novel Treatment for Chronic Pulmonary EmbolismOctober 17th, 2018
  • Northwestern Medicine Receives Prestigious Pulmonary Hypertension Association Accreditation
    Northwestern Medicine Receives Prestigious Pulmonary Hypertension Association AccreditationMarch 10th, 2017
  • Join now to see all

Committees

  • Standing member, FDA Cardiovascular and Renal Drugs Advisory Committee 2013 - Present

Professional Memberships

Hospital Affiliations

External Links

Dr. Stuart Rich, Dr. Stuart Rich, MD, Dr. S Rich